Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Overweight on Labcorp Hldgs, Raises Price Target to $306

Author: Benzinga Newsdesk | July 25, 2025 08:54am
Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Hldgs (NYSE:LH) with a Overweight and raises the price target from $283 to $306.

Posted In: LH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist